Semaglutide Might Help with Fatty Liver
- Fact-checked by Dr. Desiree Granados
Fatty liver disease silently plagues about 25% of the global population, presenting a considerable health challenge. Amid the search for effective treatments, a glimmer of hope has emerged from recent studies concerning semaglutide.
In this article, we’ll explore semaglutide’s potential to combat fatty liver disease, shedding light on how it works, its efficacy, and what, if anything, it can do for those struggling with FLD.
What Is Fatty Liver Disease?
Fatty liver disease, also known as hepatic steatosis, occurs when fat builds up in the liver. This condition can be divided into two classifications: alcoholic fatty liver disease (AFLD) and non-alcoholic fatty liver disease (NAFLD).
AFLD stems primarily from excessive alcohol intake, whereas NAFLD is associated with various causes such as obesity, insulin resistance, and high levels of triglycerides in the blood. About 100 million Americans suffer from NAFLD.
What Causes Fatty Liver Disease?
AFLD is caused by excessive alcohol consumption. NAFLD, however, can be triggered by a variety of things, including:
- Obesity: High levels of body fat, especially around the abdomen, can significantly increase one’s risk of NAFLD.
- Type 2 Diabetes: This condition affects the way the body processes glucose, often leading to excess fat storage in the liver.
- High Cholesterol and Triglycerides: Elevated levels of lipids in the blood are linked to an increased risk of fatty liver disease.
- Poor Diet: A diet high in saturated fats, processed foods, and sugars can contribute to the development of NAFLD.
- Sedentary Lifestyle: Lack of physical activity can lead to obesity and other conditions that are risk factors for NAFLD.
Is Semaglutide Good for Fatty Liver Disease?
Semaglutide, a medication primarily used to treat type 2 diabetes and obesity, has recently gained attention for its potential benefits for those with NAFLD, including its more severe form, Non-Alcoholic Steatohepatitis (NASH). Studies have proven that semaglutide can improve liver function in those with NAFLD by reducing liver fat content and liver stiffness.
This effect can be attributed to semaglutide’s ability to promote weight loss and improve insulin sensitivity, both of which are risk factors for fatty liver disease. However, it’s important to note that while these initial results are promising, more research is needed to fully understand the long-term impact of semaglutide on fatty liver disease.
Can Semaglutide Help HIV Patients with Fatty Liver?
Fatty liver disease can be particularly concerning for individuals living with HIV due to the added metabolic complications associated with both the condition and the antiretroviral therapy used in HIV treatment.
Initial findings suggest that semaglutide’s ability to improve insulin sensitivity and promote weight loss could improve the health of HIV patients with fatty liver disease by reducing their liver fat content. However, more research is needed to fully understand the safety and efficacy of using semaglutide for fatty liver disease in HIV patients.
What Are the Risks of Using Semaglutide for Fatty Liver?
Like all medications, semaglutide carries side effects and risks, especially when used off-label for conditions like fatty liver disease. Some of those side effects and risks include:
- Gastrointestinal Issues: The most common side effects of semaglutide are gastrointestinal in nature, including nausea, vomiting, diarrhea, and constipation.
- Risk of Low Blood Sugar (Hypoglycemia): For patients with diabetes, there is an increased risk of hypoglycemia, especially when semaglutide is combined with other diabetes medications.
- Pancreatitis: Semaglutide involves an increased risk of pancreatitis, a serious and potentially life-threatening condition (although this risk is low).
- Thyroid C-cell Tumors: In animal studies, semaglutide has been linked to a type of thyroid tumor. It remains uncertain if this risk applies to humans, but it should still be a point of consideration for those considering long-term usage of the drug.
- Kidney Problems: Some patients may experience a worsening of kidney function when taking semaglutide, particularly those who have pre-existing kidney issues or are taking medications that affect kidney function.
Conclusion
While initial studies indicate many beneficial effects of semaglutide such as improved liver function, weight loss, and decreased liver fat content, it’s crucial to speak with a healthcare professional before taking any drug for an off-label purpose.
If you’re seeking to lose weight and have struggled to do so through diet and exercise, the Sanctuary Wellness Institute offers prescriptions for semaglutide for weight loss. When you obtain your semaglutide prescription through the Sanctuary, you can meet with a doctor online and get your medication delivered straight to your home.
Book a complimentary evaluation today to discover whether semaglutide for weight loss is right for you.
How we reviewed this article:
- Paige Fowler (2023). Fatty Liver: Causes, Symptoms, and Treatment
https://www.webmd.com/hepatitis/fatty-liver-disease - Mayo Clinic (2023). Nonalcoholic fatty liver disease
https://www.mayoclinic.org/diseases-conditions/nonalcoholic-fatty-liver-disease/symptoms-causes/syc-20354567 - Sanjay Bandyopadhyay, Saibal Das, Shambo Samrat Samajdar, Shashank R Joshi (2023). Role of semaglutide in the treatment of nonalcoholic fatty liver disease or non-alcoholic steatohepatitis: A systematic review and meta-analysis
https://pubmed.ncbi.nlm.nih.gov/37717295/ - Liz Highleyman (2024). Semaglutide improves fatty liver disease and inflammation in people with HIV
https://www.aidsmap.com/news/mar-2024/semaglutide-improves-fatty-liver-disease-and-inflammation-people-hiv - Mayo Clinic (2024). Semaglutide (Subcutaneous Route)
https://www.mayoclinic.org/drugs-supplements/semaglutide-subcutaneous-route/side-effects/drg-20406730?p=1 - Cathy Cassata (2023). I Took Ozempic, Then I Got Pancreatitis
https://www.healthline.com/health-news/ozempic-side-effect-pancreatitis - Mark M. Smits and Daniël H. Van Raalte (2021). Safety of Semaglutide
https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.645563/full - Jane F. (2023). Kidney Concerns? A Look at Wegovy and Ozempic’s Effects on Kidney Function
https://www.linkedin.com/pulse/kidney-concerns-look-wegovy-ozempics-effects-function-jane-fadesere
Current Version
March 30, 2024
Written By
Jake Peter
Fact-checked By
Dr. Desiree Granados
Editorial Process
Our Editorial Process
Jake Peter received his journalism degree from Emerson College and has been writing content for the Sanctuary Wellness Institute since 2021. He is passionate about all things cannabis.